20/04/2020 | Point of view
In this PoV, Mike Motto and Penelope Larson from our Intouch Group partner discuss how these changes create new opportunities for pharmaceutical manufacturers to enhance their existing payer relationships while also delivering for healthcare providers (HCPs) and patients faced with navigating their new access and reimbursement realities.
Download the PoV here |
Read the full article at www.intouchsol.com